Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China - MarketWatch (press release)
Posted by admin / Under Secretagogue
Eisai to Launch Rapid-acting Insulin Secretagogue Glufast(R) in China MarketWatch (press release) Glufast is a phenylalanine derived rapid-acting insulin secretagogue originally discovered and developed by Kissei Pharmaceutical Co., Ltd. Eisai obtained ... |
Published on Monday 6th of September 2010 03:13:07 PM




Share this!